Inhaled smoking cessation therapy superior to other treatments
Drug Discovery World
DECEMBER 4, 2023
Looking ahead, we are committed to advancing QN-01 into the next stage of clinical development and will be working closely with FDA and MHRA to bring this treatment option to the millions of smokers who want to quit.” QN-01 achieved targets for both peak nicotine concentration and time to achieve peak nicotine concentration.
Let's personalize your content